Prospective study the prevalence of different candida strains and their sensitivity to different antimycotic treatment in women with vulvovaginal candidosis;Prospektivní sledování zastoupení a citlivosti jednotlivých druhů kvasinek u žen s vulvovaginá lní kandidózou

Ceska Gynekologie

Volumn 72, Issue 1, 2007, Pages 27-32

  Vrablik J ^b   Masata J ^a   Jedlickova A ^a   Hajickova M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Candida glabrata; Candida krusei; Candida lusitaniae; Candida parapsilosis; Candida tropicalis; Clotrimazol; Econazol; Fluconazol; Itraconazol; Ketoconazol; Nystatin; Pimaricin; Sacharomyces cerevisiae

Indexed keywords

EID: 33847044001     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Beigi, RH., Meyn, LA., Moore, DM., et al. Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet. Gynecol., 2004, 104, p. 926-930.
2. Ben-Haroush, A., Yogev, Y., Kaplan, B. The importance of diagnostic work-up in the management of candidal vulvovaginitis. A prospective study. Clin. Exp. Obstet. Gynecol., 2004, p. 113-116.
3. Cassone, A., De Bernardis, F., Torososantucci, A. An outline of the role of anti-Candida antibodies within the context of passive immunization and protection from candidiasis. Curr. Mol. Med., 2005, 5, p. 377-382.
4. Corsello, S., Spinillo, A., Osnengo, G., et al. An epidemiological survey of vulvovaginal candidiasis in Italy. Eur. J. Obstet. Gynecol. Reprod.Biol., 2003, 10, 110, p. 66-72.
5. Cybulski, Z., Krzeminska-Jaskowiak, E., Majewski, P., et al. Enzyme production and biotypes of vaginal Candida albicans. Pol. J. Microbiol., 2005, p. 227-231.
6. Dennerstein, G. Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet. Gynecol., 2005, 1493, author reply 1494.
7. De Vos, MM., Cuenca-Estrella, M., Boekhout, T., et al. Vulvovaginal candidiasis in a Flemish patient population. Clin. Microbiol. Infect., 2005, 11, p. 1005-1011.
8. Fernandez Limia, O., Lantero, MI., Betancourt, A., et al. Prevalence of Candida albicans and Trichomonas vaginalis in pregnant women in Havana City by an immunologic latex agglutination test. Med. Gen. Med., 2004, 15, 6, p. 50.
9. Naidu, AS., Fowler, RS., Martinez, C., et al. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates. J. Reprod. Med., 2004, 49, p. 800-807.
10. Hamad, M., Muta'eb, E., Abu-Shaqra, Q., et al. Utility of the oestrogen-dependent vaginal candidosis murine model in evaluating the efficacy of various therapies against vaginal Candida albicans infection. Mycoses, 2006, 49, p. 104-108.
11. Holland, J., Young, ML., Lee, O., C-A Chen, S. Vulvovaginal carriage of yeasts other than Candida Sex albicans. Transm. Infect., 2003, 79, p. 249-250.
12. Mašata, J., Jedličková, A., et al. Infekce v gynekologii a porodnictví. Maxdorf, 2004, p. 50-56.
13. Mujica, MT., Finquelievich, JL., Jewtuchowicz, V., Iovannitti, CA. Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001. Rev. Argent. Microbiol., 2004, 36, p. 107-112.
14. Owen, MK., Clenney, TL. Management of vaginitis. Am. Fam. Physician, 2004, 1, 70, p. 2125-2132.
15. Richter, SS., Galask, RP., Messer, SA., et al. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J. Clin. Microbiol., 2005, 43, 5, p. 2155-2162.
16. Senterre, JM., Carpentier, M., Foidart, JM. Vulvovaginal candidiasis: prevalence of different Candida species in the Liege region. Rev. Med. Liege, 2005, 60, p. 882-884.
17. Sobel, JD., Wiesenfeld, HC., Martens, M., et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N. Engl. J. Med., 2004, 26, 351, p.876-883.
18. Tarry, W., Fisher, M., Shen, S., Mawhinney, M. Candida albicans: the estrogen target for vaginal colonization. J. Surg. Res., 2005, 129, p. 278-282.
19. Urunsak. M., Ilkit, M., Evruke, C., Urunsak, I. Clinical and mycological efficacy of single-day oral treatment with itraconazole (400 mg) in acute vulvovaginal candidosis. Mycoses, 2004, 47, p. 422-427.
20. Ventolini, G., Baggish, MS. Post-menopausal recurrent vaginal candidiasis: effect of hysterectomy on response to treatment, type of colonization and recurrence rates post-treatment. Maturitas, 2005, 16, 51, p. 294-198.
21. White, TC., Holleman, S., Dy, F., et al. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother., 2002, 46, p. 1704-1713.
22. Wittemer, C., Bettahar-Lebugle, K., Ohl, J., et al. Abnormal bacterial colonisation of the vagina and implantation during assisted reproduction. Gynecol. Obstet. Fertil., 2004, 32, p. 135-139.